Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.850
+0.050 (2.78%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Immuron Revenue
Immuron had revenue of 3.99M AUD in the half year ending December 31, 2024, with 584.38% growth. This brings the company's revenue in the last twelve months to 6.54M, up 82.90% year-over-year. In the fiscal year ending June 30, 2024, Immuron had annual revenue of 4.90M with 171.67% growth.
Revenue (ttm)
6.54M AUD
Revenue Growth
+82.90%
P/S Ratio
2.51
Revenue / Employee
934,518 AUD
Employees
7
Market Cap
10.15M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.90M | 3.10M | 171.67% |
Jun 30, 2023 | 1.80M | 1.04M | 135.85% |
Jun 30, 2022 | 765.19K | 619.42K | 424.91% |
Jun 30, 2021 | 145.78K | -2.37M | -94.21% |
Jun 30, 2020 | 2.52M | 131.14K | 5.49% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIMRN News
- 24 days ago - Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - GlobeNewsWire
- 2 months ago - Immuron Travelan® continued strong sales growth - GlobeNewsWire
- 2 months ago - Immuron Announces New Research Collaboration targeting Antimicrobial Resistance - GlobeNewsWire
- 2 months ago - Immuron Announces Travelan® Clinical Trial Update - GlobeNewsWire
- 4 months ago - Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th - GlobeNewsWire
- 4 months ago - Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event - GlobeNewsWire
- 4 months ago - Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 5 months ago - Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference - GlobeNewsWire